Many of the most fundamental aspects of TB disease remain unknown. For example, after exposure to the organism that causes TB, why do only some people get infected and only some of those fall ill?
- Faculty Member, Africa Health Research Institute; Associate professor, UCL
The push to end TB requires significant investment into the research and development of new diagnostics and treatments.
Scientists have found proteins in the body that promote lung inflammation which helps the bacteria that causes TB to spread throughout the lung.
Avec plus de 9 millions de cas par an, la tuberculose est un fléau mondial. Son traitement est compliqué par l’émergence des résistances. Une nouvelle voie s’ouvre : conforter l’immunité des malades.
There is an increasing focus on alternative treatment strategies, developed to treat other diseases and conditions but re-purposed to tackle TB.
Contact Mohlopheni for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Durban, South Africa
- Website
- X (formerly Twitter): @mohlopheni
- Article Feed
- ORCID
- Joined
